<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:030040ff-560b-4409-a528-b0a4985846f5,g:a08ffb7c-8f7b-4dfa-baa8-fb9b7c0ad039,d:161eee61d83a4777ae31256ec5e9d4b5--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cstl-20220401</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV80L2ZyYWc6YzYyMDk0ZGI2MzY2NDEyYTg4NTU4OTEyMmFkZjNmYzgvdGFibGU6MTZjNjc3OTNiODZlNDM4MWI0ZDE4YjgyY2Q1YzllZGIvdGFibGVyYW5nZToxNmM2Nzc5M2I4NmU0MzgxYjRkMThiODJjZDVjOWVkYl8wLTEtMS0xLTc0MjA2_3de7a507-ce7c-4dae-ba06-925c9527fa19">0001447362</ix:nonNumeric><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV80L2ZyYWc6YzYyMDk0ZGI2MzY2NDEyYTg4NTU4OTEyMmFkZjNmYzgvdGFibGU6MTZjNjc3OTNiODZlNDM4MWI0ZDE4YjgyY2Q1YzllZGIvdGFibGVyYW5nZToxNmM2Nzc5M2I4NmU0MzgxYjRkMThiODJjZDVjOWVkYl8xLTEtMS0xLTc0MjA2_b8d8b4b9-d8cd-4b81-b0cf-64290244e9fc">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cstl-20220401.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001447362</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i161eee61d83a4777ae31256ec5e9d4b5_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjc4_35dab365-eca1-460d-b177-87dc3b4faefa">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8yMjY_9f14cb75-a4d8-4b00-b84b-52a7249796e3">April 1, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjc5_9f23010d-4713-4be8-8f4f-5c35f342e117">Castle Biosciences, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.814%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6Y2Q3MmQ2NTdiOTk0NDYyYzgwOGM1YzE0ZGEzY2Q3MWYvdGFibGVyYW5nZTpjZDcyZDY1N2I5OTQ0NjJjODA4YzVjMTRkYTNjZDcxZl8xLTAtMS0xLTc0MjA2_25f1c9e6-a828-47b4-8cd7-8e74cc736bee">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6Y2Q3MmQ2NTdiOTk0NDYyYzgwOGM1YzE0ZGEzY2Q3MWYvdGFibGVyYW5nZTpjZDcyZDY1N2I5OTQ0NjJjODA4YzVjMTRkYTNjZDcxZl8xLTItMS0xLTc0MjA2_b672872d-bb8a-4551-aecb-03778e7a8f36">001-38984</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6Y2Q3MmQ2NTdiOTk0NDYyYzgwOGM1YzE0ZGEzY2Q3MWYvdGFibGVyYW5nZTpjZDcyZDY1N2I5OTQ0NjJjODA4YzVjMTRkYTNjZDcxZl8xLTQtMS0xLTc0MjA2_dcfcf19e-45f7-4f83-be2b-c6906bc2886d">77-0701774</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6ZTE4ZTg0YWNhOGM4NDRmMDhhNjhhMWQxYzA4Y2E5NmIvdGFibGVyYW5nZTplMThlODRhY2E4Yzg0NGYwOGE2OGExZDFjMDhjYTk2Yl8wLTEtMS0xLTc0MjA2L3RleHRyZWdpb246YThjNjc5ZTY3YWJlNDE3YmI5YzBmZmEzZTllNDRkYzVfNA_3f614adc-ac2f-4794-9415-f26e5f882b71">505 S. Friendswood Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6ZTE4ZTg0YWNhOGM4NDRmMDhhNjhhMWQxYzA4Y2E5NmIvdGFibGVyYW5nZTplMThlODRhY2E4Yzg0NGYwOGE2OGExZDFjMDhjYTk2Yl8wLTEtMS0xLTc0MjA2L3RleHRyZWdpb246YThjNjc5ZTY3YWJlNDE3YmI5YzBmZmEzZTllNDRkYzVfOA_190b0b60-1e29-4f8d-bff9-aeb3764099a0">Suite 401</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6ZTE4ZTg0YWNhOGM4NDRmMDhhNjhhMWQxYzA4Y2E5NmIvdGFibGVyYW5nZTplMThlODRhY2E4Yzg0NGYwOGE2OGExZDFjMDhjYTk2Yl8wLTEtMS0xLTc0MjA2L3RleHRyZWdpb246YThjNjc5ZTY3YWJlNDE3YmI5YzBmZmEzZTllNDRkYzVfMTE_92248655-f702-47d6-a826-f00fb78f0af3">Friendswood</ix:nonNumeric>, <ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6ZTE4ZTg0YWNhOGM4NDRmMDhhNjhhMWQxYzA4Y2E5NmIvdGFibGVyYW5nZTplMThlODRhY2E4Yzg0NGYwOGE2OGExZDFjMDhjYTk2Yl8wLTEtMS0xLTc0MjA2L3RleHRyZWdpb246YThjNjc5ZTY3YWJlNDE3YmI5YzBmZmEzZTllNDRkYzVfMTU_adfc0d4c-9086-44a7-b235-af592155fb7f">Texas</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6ZTE4ZTg0YWNhOGM4NDRmMDhhNjhhMWQxYzA4Y2E5NmIvdGFibGVyYW5nZTplMThlODRhY2E4Yzg0NGYwOGE2OGExZDFjMDhjYTk2Yl8wLTQtMS0xLTc0MjA2_6ab6e826-76a1-48bc-b4ee-3c923439b94c">77546</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjcy_f1d7aa9f-195e-4a7a-9470-5fdbb1d5aed9">866</ix:nonNumeric>) <ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjcz_6aed29eb-3e1b-4d8a-86d4-b521edd7a19e">788-9007</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjc0_0cd9fc1d-575f-46b1-bbfe-087657e8420f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjc1_29c20766-743f-4bb4-a591-bdc80c425689">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjc2_8f692ba9-dacd-4799-85b9-1647ea63c9aa">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjc3_1640c6bc-efdf-4ed2-a9d3-3479ad721dbf">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6MzIyMmE1N2M5Mzc5NDc1ZDkxZjI4NTlhNGQyMjUwOWQvdGFibGVyYW5nZTozMjIyYTU3YzkzNzk0NzVkOTFmMjg1OWE0ZDIyNTA5ZF8xLTAtMS0xLTc0MjA2_73788fbe-aed8-4045-8dda-e13ab40dce9e">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6MzIyMmE1N2M5Mzc5NDc1ZDkxZjI4NTlhNGQyMjUwOWQvdGFibGVyYW5nZTozMjIyYTU3YzkzNzk0NzVkOTFmMjg1OWE0ZDIyNTA5ZF8xLTItMS0xLTc0MjA2_812c0c26-faeb-4968-8397-b30fb040be9a">CSTL</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGFibGU6MzIyMmE1N2M5Mzc5NDc1ZDkxZjI4NTlhNGQyMjUwOWQvdGFibGVyYW5nZTozMjIyYTU3YzkzNzk0NzVkOTFmMjg1OWE0ZDIyNTA5ZF8xLTQtMS0xLTc0MjA2_576c6ae8-9f4a-46a7-b07f-b3816de275a0">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b&#8211;2 of the Securities Exchange Act of 1934 (&#167; 240.12b&#8211;2 of this chapter).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;<ix:nonNumeric contextRef="i98187d932c7c40b3a4658eca09ced7ad_D20220401-20220401" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE2MWVlZTYxZDgzYTQ3NzdhZTMxMjU2ZWM1ZTlkNGI1L3NlYzoxNjFlZWU2MWQ4M2E0Nzc3YWUzMTI1NmVjNWU5ZDRiNV8xL2ZyYWc6ZThkMGQ2ODgzZmU1NDYxNGEwNDEzZTIyNWFiM2I2YTAvdGV4dHJlZ2lvbjplOGQwZDY4ODNmZTU0NjE0YTA0MTNlMjI1YWIzYjZhMF8zMjg0_1bee3d00-667a-4350-8b79-8199bdaec478">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange&#160;Act.&#9744;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.01&#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Castle Biosciences, Inc. (the &#8220;Company&#8221;) entered into a lease agreement (the &#8220;Pittsburgh Lease&#8221;) with ACA Concourse East Unit 3 LLC (the &#8220;Pittsburgh Landlord&#8221;) for the lease of certain office space in Pittsburgh, Pennsylvania. The Company intends to use such space for general office and laboratory use. The Company will lease approximately 20,856 square feet for the first 36 months, then an additional 23,821 square feet shall be added to the premises starting with month 37, for a total of approximately 44,677 square feet. The term of the Pittsburgh Lease will begin upon the completion of certain leasehold improvements by the Pittsburgh Landlord (the &#8220;Commencement Date&#8221;) and continue for an initial term of 126 months from the Commencement Date. The Pittsburgh Lease provides the Company with an option to extend the term of the Pittsburgh Lease for one additional five-year period. During the first six months of the lease term, the Company is required to remit base rent at a rate of $3.62 per rentable square foot per year. Beginning with month seven, the base rent will be $28.62 per square foot per year with annual increases ultimately to $34.84 per square foot per year. If the Company elects to extend the term of the Pittsburgh Lease, then the base rent for the additional five-year period will be the then-fair market rent of the leased premises, subject to a specified minimum amount. The Pittsburgh Landlord has agreed to contribute up to $2.5 million towards the cost of the leasehold improvements and the Company shall be responsible for any costs exceeding this amount. The Pittsburgh Lease also provides the Company a one-time option that would terminate the lease effective at the end of the 90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> month following the Commencement Date, subject to certain conditions. If exercised, the Company would pay an early termination fee of $2.3 million, subject to adjustment in the event the Pittsburgh Lease is amended to adjust the base rent. The Pittsburgh Lease also provides the Company a right of first refusal with respect to the lease of certain additional space in the same building.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summary of the Pittsburgh Lease does not purport to be complete and is qualified in its entirety by reference to the full text of the Pittsburgh Lease, a copy of which will be filed as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURES</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.<br/></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.479%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASTLE BIOSCIENCES, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Frank Stokes</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frank Stokes</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 7, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "cstl-20220401.htm", "description": "8-K", "secsgml_size_bytes": 36084}]
{"company-data": {"conformed-name": "CASTLE BIOSCIENCES INC", "cik": "0001447362", "assigned-sic": "8071", "irs-number": "770701774", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-38984", "film-number": "22814740"}, "business-address": {"street1": "505 S FRIENDSWOOD DRIVE", "street2": "SUITE 401", "city": "FRIENDSWOOD", "state": "TX", "zip": "77546", "phone": "866-788-9007"}, "mail-address": {"street1": "505 S FRIENDSWOOD DRIVE", "street2": "SUITE 401", "city": "FRIENDSWOOD", "state": "TX", "zip": "77546"}}
cstl-20220401
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 1, 2022
Castle Biosciences, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-38984
77-0701774
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
505 S. Friendswood Drive
,
Suite 401
Friendswood
,
Texas
77546
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (
866
)
788-9007
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value per share
CSTL
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 1.01    Entry into a Material Definitive Agreement.
On April 1, 2022, Castle Biosciences, Inc. (the "Company") entered into a lease agreement (the "Pittsburgh Lease") with ACA Concourse East Unit 3 LLC (the "Pittsburgh Landlord") for the lease of certain office space in Pittsburgh, Pennsylvania. The Company intends to use such space for general office and laboratory use. The Company will lease approximately 20,856 square feet for the first 36 months, then an additional 23,821 square feet shall be added to the premises starting with month 37, for a total of approximately 44,677 square feet. The term of the Pittsburgh Lease will begin upon the completion of certain leasehold improvements by the Pittsburgh Landlord (the "Commencement Date") and continue for an initial term of 126 months from the Commencement Date. The Pittsburgh Lease provides the Company with an option to extend the term of the Pittsburgh Lease for one additional five-year period. During the first six months of the lease term, the Company is required to remit base rent at a rate of $3.62 per rentable square foot per year. Beginning with month seven, the base rent will be $28.62 per square foot per year with annual increases ultimately to $34.84 per square foot per year. If the Company elects to extend the term of the Pittsburgh Lease, then the base rent for the additional five-year period will be the then-fair market rent of the leased premises, subject to a specified minimum amount. The Pittsburgh Landlord has agreed to contribute up to $2.5 million towards the cost of the leasehold improvements and the Company shall be responsible for any costs exceeding this amount. The Pittsburgh Lease also provides the Company a one-time option that would terminate the lease effective at the end of the 90
th
month following the Commencement Date, subject to certain conditions. If exercised, the Company would pay an early termination fee of $2.3 million, subject to adjustment in the event the Pittsburgh Lease is amended to adjust the base rent. The Pittsburgh Lease also provides the Company a right of first refusal with respect to the lease of certain additional space in the same building.
The foregoing summary of the Pittsburgh Lease does not purport to be complete and is qualified in its entirety by reference to the full text of the Pittsburgh Lease, a copy of which will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CASTLE BIOSCIENCES, INC.
By:
/s/ Frank Stokes
Frank Stokes
Chief Financial Officer
Date: April 7, 2022